ALBENZA

Product NDC
76413-145
11-digit product format
764130145
Labeler code
76413
Product ID
76413-145_f91924ce-6feb-42e5-9489-68f11d7acb77
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
albendazole
Dosage form
TABLET, FILM COATED
Route
ORAL
Labeler
Central Texas Community Health Centers
Application
NDA020666
Marketing category
NDA
Marketing start
1996-06-11
Marketing end
0000-00-00
Substance
ALBENDAZOLE
Active strength
200 mg/1
Pharmacologic classes
Anthelmintic [EPC],Cytochrome P450 1A Inducers [MoA]
NDC exclude flag
No
Listing certified through
2019-12-31
Current FDA listing
Historical FDA.report record

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
b0e27303-91cd-2fd1-e9ec-fbe22a3c3f49Product name820250325

FDA-Initiated Inactive NDC Indexing#

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
76413-145-01ALBENZA1 in 1 BOTTLETABLET, FILM COATED11
76413-145-02ALBENZA2 in 1 BOTTLETABLET, FILM COATED21

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
76413-145ALBENZA (ALBENDAZOLE) TABLET, FILM COATED [CENTRAL TEXAS COMMUNITY HEALTH CENTERS]1Legacy NDC, 2 package rows20170909_62a3f663-9e76-47f6-b089-54e4db01f697.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
199672albendazole 200 MG Oral TabletPSN62a3f663-9e76-47f6-b089-54e4db01f6971
211148Albenza 200 MG Oral TabletPSN62a3f663-9e76-47f6-b089-54e4db01f6971
211148albendazole 200 MG Oral Tablet [Albenza]SBD62a3f663-9e76-47f6-b089-54e4db01f6971
199672albendazole 200 MG Oral TabletSCD62a3f663-9e76-47f6-b089-54e4db01f6971
211148Albenza 200 MG Oral TabletSY62a3f663-9e76-47f6-b089-54e4db01f6971

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionStatus
76413-145-01764130145011 in 1 BOTTLEHistorical
76413-145-02764130145022 in 1 BOTTLEHistorical